期刊文献+

大鼠胃黏膜癌变发生发展过程中bcl-2基因与端粒酶的动态表达 被引量:3

Telomerase Activity and Expressions of bcl-2 Gene in the Process of Carcinomatous Change of Gastic Mucosa in Wistar Rats
下载PDF
导出
摘要 目的 探讨大鼠胃黏膜癌变发生发展过程中bcl 2基因表达及其与端粒酶活性的关系。方法 采用MNNG、10 %NaCl及 4 0 %乙醇灌胃建立了大鼠胃黏膜癌变模型 ,分别采用原位杂交技术及免疫组织化学方法检测大鼠胃黏膜bcl 2mRNA、蛋白表达 ,采用端粒微孔板杂交法检测胃黏膜端粒酶活性。结果 本造模方法在大鼠胃黏膜诱发出浅表性胃炎 (chronicsuperficialgastritis,CSG)、萎缩性胃炎 (chronicatrophicgastritis,CAG)、肠化生 (intestinalmetaplasia,IM )、异型增生 (dysplasia ,Dys)、胃腺癌 (gastricadenocarcinoma ,GC)等病变。大鼠从正常胃黏膜发展到胃癌 ,bcl 2基因表达及端粒酶活性均逐渐增高 ,并且两者有高度的一致性 (P <0 .0 5 )。结论 大鼠胃黏膜癌变发生发展过程中 ,癌基因bcl Purpose: To study the correlation of the expression of bcl-2 gene and telomerase activity. Methods: We detected expression of bcl-2 by using in situ hybridization and immunohistochemistry assay, and tested telomerase activity by using telomeric repeat amplification protocol (TRAP)-microtiter plate hybridization assay in rats of two groups: control, model in gastric cancer rats induced by N-methyl-N′-nitro-N-nitrosoguanidine (MN-NG), 10% sodium chloride and 40% ethanl. Results: Models of various phase of carcinomatous change of gastic mucosa in Wistar rats were estabalished, chronic superficial gastritis (CSG), chronic atrophic gastritis (CAG), intestinal metaplasia (IM), dysplasia (Dys), and gastric adenocarcinoma (GC). With the development of gastric cancer, the expression of bcl-2 gene and telomerase activity were increased by degrees, and, the former has an important correlation with the latter (P < 0.05). Conclusions: Telomerase activity has an important relation with expression of bcl-2 in the process of carcinomatous change of gastric mucosa in Wistar rats.
出处 《复旦学报(医学版)》 EI CAS CSCD 北大核心 2001年第6期479-482,共4页 Fudan University Journal of Medical Sciences
关键词 胃肿瘤 BCL-2 端粒酶 肿瘤发生 Correlation methods Tumors
  • 相关文献

参考文献3

二级参考文献19

  • 1[6]Okusa Y,Shinomiya N,Ichikura T, et al. [J]. Oncology, 1998,55(3) :258-264.
  • 2[7]Katayama S,Shiota G,Oshimura M,et al. [J]. J Cancer Res Clin Oncol, 1999,125(7) :405-410.
  • 3[8]Jong HS, Park YI, Kim S, et al. [J]. Cancer, 1999,15,86(4) :559.
  • 4[9]Suzuki K, Kashimura H, Ohkawa J, et al. [J] J Gastroenterol Hepatol,2000,15(7) :744-751.
  • 5[10]Feng JL, Funk WD, Wang S, et al. [J]. Science,1995,269:1236-1241.
  • 6[11]Sharma HW, Sockoloski JA, Perez JR, et al. [J]. Proc Natl Acad Sci USA, 1995,92:12343-12346.
  • 7[12]Blasco MA, Rizen M,Greider CW, et al. [J]. Nature Genet, 1996,12:200-204.
  • 8[13]Avilion AA,Piayzek MA, G upta J, et al. [J]. Cancer Res, 1996,56:645-650.
  • 9[14]Collins K. [J]. Curr Opin Cell Biol,1996,16(1):53-65.
  • 10[15]Zhu X, Kumar R, Mandal M, et al. [J]. Proc Natl Acad Sci USA, 1996,93:6091-6095.

共引文献92

同被引文献38

  • 1LKENO T, OTA H, SUGIYAMA A, et al. Helicobacter Pylori-induced chionic active gastritis, intestinal metaplasia, and gastric ulcen in Mongolian gerbils[J].Am J Pathol, 1999,154:951.
  • 2MATSUMOTO S, WASHIZUKA Y, MATSUMOTO Y, et al. Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter Pylori infection [J]. J Med Microbil, 1997, 46:391.
  • 3Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene is upregulated in tumor cells and during immortalization. Cell, 1997,90(4) :785-795.
  • 4Yamade K,Yajima T,Yagihashi A,et al. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopotetic cells. Jpn J Cancer Res, 2000,91 (12): 1278-1284.
  • 5Suzuki K, Kashimura H, Ohkawa J. et al. Expression of human telomerase catalytic subunit gene in cancerous and preacancerous gastric conditions. JGastroenterol- Hepatol, 2000,15 (7): 744-751.
  • 6Reichman TW, Albanell J, Wang X, et al. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression ot telomerase-associated protein. J Cell Biochem, 1997,67 (1):13-23.
  • 7Yoon KA, Ku JL, Yang JO. et al. Telomerase activity, expression of Bcl-2and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines. Iht J Mol Med, 2003,11 (30: 343-348.
  • 8Mandal M, Kumar R. Bcl-2 modulated telomerase activity. J Biol Chem,1997,272(22): 14183-14187.
  • 9FU WN, Begley JG, Killen MW, et al. Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem, 1999,274(11) :7264-7271.
  • 10HEI T K, LIU S X, WALDREN C. Mutagenicity of arsenic in mammalian cells :Role of reactive oxygen species [J]. Proc Natl Acad Sci USA, 1998,95 : 8 103-8 107.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部